oncology
Breast Cancer

Bisphosphonates linked to lower cancer rates, especially breast cancer

Benefits of the bisphosphonates may  extend beyond fracture prevention to include reductions in cancer and vascular events and possibly mortality, according to a New Zealand trial. A more in-depth analysis of a six year trial of zoledronate in older women with osteopenia has found benefits on some cancers and cardiovascular disease, consistent with those seen ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic